Medicine - Science topic

I am working on making a website which will connect and represent the research projects and events of scientists in collaboration with musicinas. This is my mission statement:

For example in the field of Engineering, Medicine, Psychology, Business etc...

Esta pregunta busca comprender el papel del trabajo social sanitario en la disminución de las barreras que dificultan el acceso a la atención médica para las poblaciones más vulnerables. Esto incluye personas en situación de pobreza, migrantes, ancianos, personas con discapacidad u otros grupos en riesgo de exclusión social. La investigación podría analizar cómo los trabajadores sociales sanitarios facilitan el acceso a servicios de salud a través de gestiones administrativas, asesoramiento, coordinación con otras instituciones y promoción de derechos. También se podría explorar si sus intervenciones logran reducir brechas en la atención médica y mejorar la equidad en los sistemas de salud.

I am a fifth-year medical student preparing to begin my clerkship soon. I am reaching out to inquire about potential research collaboration opportunities in the fields of neurosurgery, neurology, and neuroscience.

I have gained valuable experience working on various research projects throughout my studies and I am eager to further develop my skills and contribute to meaningful research in these areas. While I have not yet had the opportunity to publish my work, I am committed to advancing my knowledge the expertise in the field.

If you are aware of any ongoing projects or opportunities for collaboration, I would greatly appreciate your guidance or any connections you could provide. I am enthusiastic about the possibility of contributing to impactful research and learning from experienced professionals in the field.

Dear Researchers, Scientists, Friends,

AI is increasingly being used in medical diagnostics, including the recognition of diseases based on medical data. The question is whether AI should make diagnoses on its own or whether this should be left exclusively to doctors. Research shows that AI technology in diagnostics can improve the accuracy of diagnoses and detect diseases faster, reducing the risk of medical errors. On the other hand, AI's independent diagnosis can lead to wrong decisions, especially in unusual cases or those requiring medical context that algorithms may not be able to recognise. Therefore, perhaps the best solution is to use AI as a tool to support doctors who make final decisions based on the results of the analyses. Therefore, the question above touches on the delicate issue of trust in technology in an area where human life can be at stake. Although AI can offer impressive precision in data analysis, it cannot replace a comprehensive approach that takes into account the entire medical context and the individual needs of the patient. Decisions regarding health require not only data, but also an understanding of the human psyche and the specifics of a given case, which makes the role of a doctor crucial. In this case, AI can be a very effective support tool, but medical decisions should still be left in the hands of qualified specialists.

My following articles are related to the above issues in some aspects:

I have described the key issues of opportunities and threats to the development of artificial intelligence technology in my article below:

What is your opinion on this topic?

Please answer,

I invite everyone to the discussion,

Thank you very much,

Best regards,

I invite you to scientific cooperation,

Dariusz Prokopowicz

How to use zinc oxide nanoparticles in medicine?

Use of zinc oxide nanoparticles in medicine

Dear Researcher,

As the editor of the Blambangan Journal of Nursing and Health Sciences (BJNHS), I am pleased to invite dedicated professionals and researchers to join our peer review team. Your expertise and insights are invaluable in advancing the quality of research and scholarship within the fields of nursing and health sciences.

By serving as a peer reviewer, you will play a critical role in ensuring the integrity and excellence of the articles we publish while contributing to the growth of scientific knowledge. This collaboration also offers an opportunity to expand your professional experience and strengthen your academic profile.

We welcome experts in the following areas:

1. Nursing

2. Medicine

3. Midwifery

4. Public Health

5. Pharmacy

Other related disciplines

As a token of our gratitude for your valuable contributions, you will also have the opportunity to publish your articles in our journal free of charge.

If you are interested in becoming a peer reviewer, kindly email us at bjnhs.scholar@gmail.com with the following details:

1. Name:

2. Contact email:

3. Affiliation:

4. Area of expertise:

5. Scopus ID:

6. Google Scholar ID:

Your participation will be instrumental in maintaining the high standards of our publication. We look forward to welcoming you to our peer review team and working together to make a significant impact in the nursing and health sciences community.

Thank you for considering this meaningful opportunity.

Best regards,

Mahmud Ady Yuwanto

Editor-in-chief

Blambangan Journal of Nursing and Health Sciences (BJNHS)

The Blambangan Journal of Nursing and Health Sciences (BJNHS) is delighted to announce a call for papers for publication in Volume 3, Issues 1 and 2, 2025. We welcome high-quality original research articles, reviews, and case studies in the fields of nursing and health sciences.

- No Publication Fee: Submissions for these upcoming issues will be published free of charge.

- Open Access: All articles are freely accessible to the global academic and professional community.

- Rigorous Peer Review: A robust peer review process ensures the quality and credibility of your work.

We welcome original research articles, review articles, case studies, and other scholarly works in the following areas:

- Nursing

- Public Health

- Medicine

- Midwifery

- Pharmacy

- Health Education

- Healthcare Management

- Other health-related disciplines

Manuscripts should be prepared according to the journal’s submission guidelines, available on our website. Please submit your articles directly through the following link: https://blambangan-scholar.com/index.php/BJNHS/about/submissions

Submissions for Volume 3, Issues 1 and 2, will be accepted until further notice. Early submissions are encouraged for timely review and publication.

We look forward to receiving your valuable contributions and collaborating with you to advance the fields of nursing and health sciences. Should you have any questions or require assistance, feel free to contact us.

Warm regards,

Email: bjnhs.scholar@gmail.com

We are excited to announce our second edition of the International Conference: Molecular Biology- Current Aspects and Prospects that will be held in Cluj-Napoca, Romania from November 4–7, 2025. This event invites researchers from around the globe, including undergraduate and graduate students, researchers, research group leaders, professors, and even high school students. Whether you’re just starting your journey in molecular biology or you’re an experienced professional, this is a fantastic opportunity to delve into the complexities of the field and connect with a vibrant international scientific community. Are you curious to learn more? Visit our website to explore the details and start your preregistration today!

Conference Website: https://icmb2025.stiinta-cercetare.ro/

Whether you’re a student or a researcher fueled by your love for molecular biology, ICMB 2025 is the place to be. Let’s come together in Cluj-Napoca to shape the future of science and innovation. We can’t wait to meet you all this year in the vibrant city of Cluj-Napoca!

Molecular Biology (Current aspects and Prospects) on Microorganisms, Plants and Animals.

Pre-registration: 01.02.2025 - 28.02.2025

Early bird: 01.03.2025 - 15.08.2025

Late bird: 15.08.2025 - 15.09.2025

Very-Late bird: 15.09.2025 - 15.10.2025

Abstract submission deadline: 01.03.2025 - 15.06.2025

Abstract selection announcement: 30.07.2025 (for talk or poster)

Considering the importance which sexual problems have in the practice of psychiatry, medicine, psychology, and counselling of every sort, it is disconcerting to realize what scant bases there have been for over-all statements that have been made in this field. (Alfred Kinsey)

Colleagues: Academic Medicine & Surgery is open for submissions:https://academic-med-surg.scholasticahq.com/for-authors The journal accepts original research, practice innovations, educational advances in medicine and surgery, reviews, case reports, clinical images, surveys, and data notes. There are NO article processing charges, and the turnaround time from submission to decision is less than 15 days.  Submit your work today! editor@universitymedicalpress.org

Let’s explore the growing impact of nutraceuticals on human health: their bioactive compounds are gaining recognition for their integrative roles in disease prevention, chronic condition management, and enhancing overall well-being.

A special issue of Nutrients MDPI (Nutrition and Public Health section) is open for manuscript submissions until July 20, 2025.

Link: https://www.mdpi.com/journal/nutrients/special_issues/30971M2880

Guest editors Dr. Michele Antonelli and Dr. Davide Donelli encourage submissions that deepen our understanding of nutraceuticals’ efficacy, safety, and regulatory frameworks. Accepted papers will be published online with open access.

Let’s discuss how nutraceuticals are shaping the future of evidence-based medicine!

🧬🌿

Hello,

The monkey virus SV40 contaminated an unknown number of batches of the Polio vaccine administered between 1955 and 1963. Since then, SV40 has been found to transform cell lines and cause tumors in laboratory animals.

Why then, is SV40 genetic material or antigen not tested for regularly in human tumors? American baby boomers who may have received the contaminated vaccine have a relatively high rate of cancer. Why not make SV40 testing part of the standard procedure for characterizing tumors in this age group? We certainly have the technology to do so.

Additionally, it is still unknown if SV40 can be vertically transmitted to offspring through genome integration. Why then, are pediatric and young adult tumors also not regularly tested for SV40?

Thanks!

📢 Call for Papers: New Asian Journal of Medicine, Volume 2 – Issue 2, 2024 📢 We are delighted to announce that the New Asian Journal of Medicine (NAJM) is now inviting submissions for our 2024 issues. In our commitment to advancing global medical knowledge, we are offering free publication for all articles accepted in 2024. Submission Deadline: 🗓️ July 31, 2024 Topics of Interest Include, But Are Not Limited To: Clinical Medicine Public Health Initiatives Medical Ethics Infectious Diseases Chronic Disease Management Medical Imaging Surgical Techniques Healthcare Policy Patient Safety and Quality Improvement Medical Education We welcome submissions from researchers across the globe, aiming to reflect the diverse nature of medical science and practice. Types of Submissions Accepted: Original Research Narrative Reviews Systematic Reviews Editorials Clinical Trials Perspectives Opinions Letters to the Editor Commentaries Submission Guidelines: All submissions must adhere to NAJM guidelines and are subject to a robust peer review process to maintain the highest standards of scholarly integrity and scientific excellence. How to Submit: Please submit your manuscripts through the NAJM online submission system at [https://nasianjmed.com/index.php/najm/announcement/view/2]. If you encounter any difficulties or have questions, contact our editorial office at [editor@nasianjmed.com].

Can AI combined with medicine cure cancer, leukaemia and other terminal diseases?

Are there any recent developments or plans to introduce a DM (Doctorate of Medicine) course in Anatomy, and what would be its potential focus areas and impact on the field?

How do you think artificial intelligence can affect medicine in real world. There are many science-fiction dreams in this regard!

but how about real-life in the next 2-3 decades!?

I am a senior medical student in Zagazig University faculty of medicine (Egypt) with a strong interest in neurology, cardiology, and hematology/oncology, and I am eager to expand my research experience in these fields. I have foundational knowledge in medical research methods such as SRMA and have participated in clinical and laboratory-based projects during my studies.

I would like to inquire if there are any ongoing research projects or collaborations within these specialties where I could contribute, either through data analysis, literature reviews, or hands-on assistance in clinical studies. I am also open to participating in interdisciplinary projects related to general medicine.

Any advice or suggestions for getting involved in current research initiatives or learning opportunities in these areas would be greatly appreciated.

Thank you!

How is polylactic acid used in medicine?

Hello, I’m a second-year medical student eager to develop my research skills, particularly in cardiology and the surgical field. I’m looking for guidance on how to start exploring research opportunities in these areas. Does anyone have any idea where to get started?

Dear Scientists...

Hello everyone sincerely.

Today (November 3, 2024), the 9th World One Health Day...

I would like to open a topic that I am curious about for discussion. If you share your valuable opinions, I would be grateful.

Some scientists say the following when speaking about ONE HEALTH or in their scientific articles: The term "One Health" is not new. In fact, the origin of the idea begins with Hippocrates. Because they say, "Hippocrates was the first person to define and say that diseases are affected by the environment, air, and water."

Okay, it is impossible not to agree with this.

But as far as we know, during the time Hippocrates lived, there was "only" Medicine (human medicine). Even under the conditions of that day, there was no scientific Veterinary Medicine yet. The first scientific Veterinary Medicine education had started in 1762.

If "One Health is a collaborative, multisectoral, and transdisciplinary approach - working at local, national, and global levels - to achieve optimal health and well-being outcomes recognizing the interconnections between people, animals, plants, and their shared environment." how can Hippocrates be a "pioneer"? Also, since the concept and approach of "collaborative, multisectoral, and transdisciplinary approach" emphasized in the definition above did not exist during the Hippocratic period, isn't it contradictory to extend the "pioneer" of the ONE HEALTH THOUGHT beyond Virchow?

Moreover, Dr. Virchow's "There is no dividing line between human medicine and animal medicine - nor should there be. Even if the objects studied are different, the experience to be gained forms the basis of all medicine." Similar to the proposition, there is no call or proposition for "interprofessional cooperation" in Hippocrates... Unless, of course, the scientific archive is misleading me...

I am curious about your thoughts on this subject.

Best regards.

Rüştü TAŞTAN (rustu_tastan@yahoo.com.tr )

Nanotechnology Based Medicine

#Nanotechnology #Medicine #HealthcareInnovation #FutureOfMedicine

Dr. Faria is associated with Department of Biochemistry (U38-FCT), Faculty of Medicine, University of Porto , 4200-319 Porto, Portugal.

As I teach disabilities and we talk about causes, treatment etc. Certain disabilities like intelectual impairment and autism along with epilepsy where cause is microcephaly, low birth weight still there is no treatment. It's life time dependency on medicine to avoid fits.

Acabei de publicar um livro sobre a ética da emancipação da medicina tradicional moçambicana:

Na sua opinião, o que deve acontecer para que haja maior valorização da medicina tradicional?

Cure of cancer?, respectfully to whom it may concern:

If I found a cure of cancer, I’m wondering what I should do with it? I’m just coming out of a 40 days fast of only drinking maple syrup and pure lemon juice plus a little cinnamon powder and nothing else since I had unimaginable pain in my colon end. I figured out that although we humans can last for weeks on this diet /fast, cancer has no food on that and just goes away and the pain is gone too. I received this prescription by tuning in into the HeilstrOm and I figured out that it also enhances the reception of the HeilstrOm greatly, which brings great happiness too, as I describe in my book

Best regards, hope this helps someone

Chris K. Frueh

Independent Researcher

Apollo Medicine is coming up with a special issue on Metabolic Syndromes.

Which one is more logical admission age to medical study, UK or US criteria ?

I want to study medicine, become a doctor. What courses should I self-study?

How does Homeopathy Artificial Intelligence relate the Innovative Implications of Revolutionary Role in Homeopathic Medicine?

Does anyone know of any research papers on experimental drug effect analysis using deep learning? If so, I would appreciate it if you could share the name or link with me. That would be greatly helpful.

Additionally, I would love to hear your thoughts on experimental drug effect analysis and what key points should be included when writing a paper on this topic, especially when I'm not allowed to share the dataset or details of the experiment itself.

MOST human actions are subconscious. The more close-ended the task, the easier to automate. Perhaps SOME subconscious human acts are more close-ended, therefore easier to automate.

1)

2)

3)

In the identified case of familial desminopathy (T341P DES mutation in heterozygous state), the son has bradycardia, but the father did not have bradycardia. How can this fact be explained?

What is the best solution for the dilemma between evidence-based medicine (EBM) for populations and for individuals, which arises from the tension between general recommendations based on population-level data and the need to tailor medical decisions to an individual’s unique circumstances? What percentage of people in your practice require tailored care?

I am reaching out to seek your advice regarding an issue I have been experiencing with the journal of Annals of Medicine. Our manuscript was accepted on 19 April 2024, and the editorial board told us the proof would be sent to us within 48 hours. However, despite multiple follow-ups, we have yet to receive the proof until now. Each time we contact the journal, we are informed that my paper is undergoing an additional check.

We have try to contact the Taylor&Francis, which is the publication company of Annals of Medicine, many times, but they never reply us.

Has anyone else encountered a similar situation? If so, how did you manage to resolve it? Any advice or suggestions on how I might expedite this process or get a clearer response from the journal would be greatly appreciated.

Thank you in advance for your insights and assistance.

If then which medicine production and name of the medicine what's is that?

What are the most pressing ethical concerns surrounding the use of genetic engineering in agriculture, medicine, and other fields?

I was on line with famous nephrologist and come to know about kidneys treatment by allopathic medicine.

Then my question ❓ is kidney will get back normal' position.

Preparing a review about potential distinct effects of North and South poles (or upward/downward) in biology, chemistry, chirality, etc, I would appreciate any signaling of publications to supplement a databank dedicated to this overlooked parameter, whether confirming or invalidating.

Also, any comments, exchanges or collaboration will be welcome.

European Society of Medicine sent an invitation for a special theme issue on COVID-19. Is this invitation genuine?

📢 Call for Papers: New Asian Journal of Medicine, Volume 2 – Issue 2, 2024 📢 We are delighted to announce that the New Asian Journal of Medicine (NAJM) is now inviting submissions for our 2024 issues. In our commitment to advancing global medical knowledge, we are offering free publication for all articles accepted in 2024. Submission Deadline: 🗓️ July 31, 2024 Topics of Interest Include, But Are Not Limited To: Clinical Medicine Public Health Initiatives Medical Ethics Infectious Diseases Chronic Disease Management Medical Imaging Surgical Techniques Healthcare Policy Patient Safety and Quality Improvement Medical Education We welcome submissions from researchers across the globe, aiming to reflect the diverse nature of medical science and practice. Types of Submissions Accepted: Original Research Narrative Reviews Systematic Reviews Editorials Clinical Trials Perspectives Opinions Letters to the Editor Commentaries Submission Guidelines: All submissions must adhere to NAJM guidelines and are subject to a robust peer review process to maintain the highest standards of scholarly integrity and scientific excellence. How to Submit: Please submit your manuscripts through the NAJM online submission system at [https://nasianjmed.com/index.php/najm/announcement/view/2]. If you encounter any difficulties or have questions, contact our editorial office at [editor@nasianjmed.com].

A new medicine PCSK9 inhibitor for lowering LDL has been developed.How does PCSK9 inhibitor differed from statin which has earlier been used s​i​nce many years to lower cholesterol levels in the blood.

Over the past few years, there has been tremendous advancement in artificial intelligence (AI). Faculty from across the Yale Department of Internal Medicine are using AI as a tool to help improve the way they learn, teach, conduct research, and advance the field of medicine. “By using the power of AI, we are unlocking new opportunities to improve the way we conduct research and teach students—all with the ultimate goal of making health care better for our patients.”

source: Gary Désir, MD, Paul B. Beeson Professor of Medicine

https://medicine.yale.edu/news-article/artificial-intelligence-medical-education-research-patient-care/

Yes. Specifically https://www.researchgate.net/publication/382049802_Correcting_Cell_Errors .

I just had an email from the European Society of Medicine asking for a contribution to the journal Medical Research Archives. There is a similar journal on Cabell's published by KEI publishers, however I am unsure if this is the same journal. The European Society of Medicine from the website seems legit. Can anyone offer their personal experiences with the European Society of Medicine?

Generally life extension and anti-aging. A lower death rate cancels out a low birthrate. https://www.researchgate.net/publication/382049802_Correcting_Cell_Errors

It is known that patients with desminopathy often die from pneumonia. Have pathomorphological studies of the lungs been performed in patients with desminopathy?

The focus is on the lack of research for culturally tailored interventions to provide effective treatment for the NA/AN population. There are cultural barriers surround distrust, misinterpretation, disparities between Western medicine and traditional healing, and more.

I need materials on intersection between literature and medicine.

I'd trying the several countries with several religions on young and older. what are which books so far. Sound Medicine, Music Medicine on many religions working now.

Respected researchers. Our team would be happy to work with anyone who is interested in contributing to the writing of a single review paper on veterinary homoeopathy. The collaborator ought to be sincere and have some writing experience in the scientific field or publishing. You can directly message me on ResearchGate or email me at dr.abrar79@gmail.com with a brief introduction about yourself.

Warm Regards

Dr. Abrar

Scientist, Department of Medicine

GADVASU, Ludhiana, Punjab

A reviewer is needed for a WOS journal with general medicine topics.

should be at least an associate professor.

Inflation of unqualified unv-diplomas cause unemployment among graduates. Children of high social statue families most will be employed ! While others, most will be unemployed or underemployed. With board exams not only graduates but also universities will also be objectively classified for their BA/BS.

Dear colleagues,

I have received an invitation to the Global Conference on Development in Medicine, Science, and Education (GCDMSE - 2024), but I need to find out the organizers. Does anyone know more and can provide me with information, experiences and the like? Thanks a lot and best regards

Ottomar Bahrs

There are many indications that artificial intelligence technology can be of great help in terms of discovering and creating new drugs. Artificial intelligence can help reduce the cost of developing new drugs, can significantly reduce the time it takes to design and create new drug formulations, the time it takes to conduct research and testing, and can thus provide patients with new therapies for treating various diseases and saving lives faster. Thanks to the use of new technologies and analytical methods, the way healthcare professionals treat patients has been changing rapidly in recent times. As scientists manage to overcome the complex problems associated with lengthy research processes, and the pharmaceutical industry seeks to reduce the time it takes to develop life-saving drugs, so-called precision medicine is coming to the rescue. It takes a lot of time to develop, analyze, test and bring a new drug to market. Artificial intelligence technology is particularly helpful in this regard, including reducing the aforementioned time to create a new drug. When creating most drugs, the first step is to synthesize a compound that can bind to a target molecule associated with the disease. The molecule in question is usually a protein, which is then tested for various influencing factors. In order to find the right compound, researchers analyze thousands of potential candidates of different molecules. When a compound that meets certain characteristics is successfully identified, then researchers search through huge libraries of similar compounds to find the optimal interaction with the protein responsible for the specific disease. In contrast, many years of time and many millions of dollars of funding are required to complete this labor-intensive process today. In a situation where artificial intelligence, machine learning and deep learning are involved in this process, then the entire process can be significantly reduced in time, costs can be significantly reduced and the new drug can be brought to the pharmaceutical market faster by pharmaceutical companies. However, can an artificial intelligence equipped with artificial neural networks that has been taught through deep learning to carry out the above-mentioned processes get it wrong when creating a new drug? What if the drug that was supposed to cure a person of a particular disease produces a number of new side effects that prove even more problematic for the patient than the original disease from which it was supposed to be cured? What if the patient dies due to previously unforeseen side effects? Will insurance companies recognize the artificial intelligence's mistake and compensate the family of the deceased patient? Who will bear the legal, financial, ethical, etc. responsibility for such a situation?

I described the key issues of opportunities and threats to the development of artificial intelligence technology in my article below:

OPPORTUNITIES AND THREATS TO THE DEVELOPMENT OF ARTIFICIAL INTELLIGENCE APPLICATIONS AND THE NEED FOR NORMATIVE REGULATION OF THIS DEVELOPMENT

In view of the above, I address the following question to the esteemed community of scientists and researchers:

What do you think about this topic?

What is your opinion on this issue?

Please answer,

I invite everyone to join the discussion,

Thank you very much,

Best wishes,

Dariusz Prokopowicz

Hello

Are diuretic medicine, thiazide type

Inhibits Na absorption from DCT or PCT?

Has medicine become a trade and not a humanitarian profession, but rather a commercial and investment profession?

I'm a current medicine student and I'm in my first scientific initiation in my graduation. Currently, me and my professor are having some troubles with contamination in our cells. This is a bottle with HCT-116 cells (colorretal cancer). This cells were, previously frozen with contaminated fetal bovine serum. My professor said she thought she treated the cells, but this contamination keep returning. We supplement our media with penicilin and B- anfotericin at 1% each. The weird thing is: The bottle keeps healthy and, suddenly, from one day to another, these clouds appears and the bottle liquid looks cloudy. Could anyone, please, help me by advising what could I do or what fungus is this (If this is a fungus)?

Most of the researchers use to teach at university. In some careers, professionals who exert their profession without doing research share teaching spaces. When I was a chemistry student, 100% of my teachers were researchers ranging from PhD candidates to experts in their respective fields. While it may seem logical for researchers to be the best candidates to teach in fields such as chemistry or biology, what about healthcare-related fields like medicine, pharmacy, or biochemistry? Who is better suited to lead a class, a researcher or a professional, or both, each one in different subjects? We can distinguish between basic and clinical subjects. I am interested in hearing your thoughts on this matter.

I have reviewed multiple health literacy instruments. The most popular are REALM, TOFHLA, Newest Vital Sign (NVS), and HLS-EU-Q (and their modifications/lingual adaptations).

I've noticed that health literacy tests were mostly focused on reading and numeracy skills. However, there are multiple aspects of health literacy, including noticing/tracking symptoms, remembering and applying newly-acquired medical knowledge, patient's capability of discussing (or sometimes arguing) with a doctor or insisting on taking some tests. Of course, it is not possible to measure all of the aspects of health literacy given the shortage of time for healthcare personnel.

I would appreciate it if you share some methods or techniques you use to understand a patient's health literacy (or identify low-literate patients).

Do traditional healers rely on their medicine if they are sick of they do go to clinic/hospitals

The causes of the medicine?

how effective it is on humans?

how it is made?(i.e how is the medicine made? what are the components used to make it?)

total info about its

please give me feedback about this journal...Plos Medicine?

I want to publish my first year phd research work in high impact factor I dont know i will be succeeded or not but i just want to try. Though my study is very simple but i just practiced and got some results

I've attached two images. One has Elsevier's name on the journal's cover and Wolters Kluwer's on the other.

a

Coco G. WTClub Commemorative

www. Azure Arc cloud; www. Azure Internet.com; Ai; Multi cloud Server applications; www.

NCBI.nlm.NIH.GOV/UNICEF/UN; ml; Hybrid Cloud; THINKSPEAK; Smart Lagos Arsenic

Water Quality Research Metals (SLAWQRM APP) Model Applications; (IaaS) (PaaS) (SaaS);

Https://www.ncbi.nlm.nih.gov/UNICEF.UN/ Mortality and Primary Causes of Death in

Mothers of Children / NIH / National Library of Medicine / (IaaS) (SaaS) Digital Output; (D) (Qin) flow; impacting Model (IaaS) Community. (PaaS) Maternal Healthcare. (PaaS) Satellite.

(SaaS) Clinics. (CMHSC). (Shared Networking);

(IaaS) (PaaS) (SaaS)Digital Output; (D) (Qin) flow; to Smart (PaaS) Lagos State (SaaS) Arsenic Water Quality (Shared Networking) Research Metals (SLAWQRM APP) Model Applications; (IaaS) (PaaS) (SaaS) Online (AQUATIC AZURE WETLANDS Television (TV).

(SaaS)

impacting Metalliferous Contaminants Pollutant Effluent Events Systems; (SaaS) Digital Output; (D) (Qin) flow; to Coastal Federal highway’s flash waves flooding’s; dynamic cyclical riverine fate conveyor, transportation (Qin) flow; to Local Government Council Area roadway’s Storms Water Runoff; Pollutants Monitoring & Management Systems;(SaaS) Digital Output; (D) (Qin) flow; to

📷

Impacting Midstream (SaaS) Digital Output; (D) (Qout) flow; to and in to YEWA River (SaaS)

Digital Output; (D) (Qout) flow; to OLOGE River (SaaS) Digital Output; (D) (Qout) flow; to OGUN River (SaaS) Digital Output; (D) (Qout) flow; to OSHUN River (SaaS) Digital Output; (D) (Qout) flow; to Midstream (IaaS)(PaaS) (SaaS)(Shared Networking);

📷 Aleia Hobbs World Fastest 400Meter Hurdle

📷 📷

📷

https://www.facebook.com/share/r/JkHMSeLVwdZFZVrS/?mibextid=oEMz7o

Https://www.ncbi.nlm.nih.gov.unicef.un/ Mortality and Primary Causes of Death in Mothers of

Children. / NIH / National Library of Medicine / impacting Model (IaaS) Community. (PaaS)

Maternal Healthcare. (PaaS) Satellite. (SaaS) Clinics. (CMHSC). (SaaS) (Shared Networking);

A patient with desminopathy (mutation Thr341Pro DES in a heterozygous state) with the progression of the disease has a decrease in taste and smell, immunosuppression, and an increase in IgA in the blood.

Oddly enough, but all this is characteristic of infections, including viral ones. For example, it is known that if the hepatitis C virus is not treated, then death will occur in 20 years.

In the identified case of late onset desminopathy, muscle weakness manifests itself at the age of 30, and death occurs 20 years after the onset of the disease.

Dear Colleagues,

Academic Medicine & Surgery is accepting manuscripts that span the breadth and depth of medicine and surgery. FREE to publish, turnaround time is ~2 weeks. Article types accepted include original research, practice innovations, data notes, technical notes, clinical images, case reports, and survey studies.

Submit here: https://academic-med-surg.scholasticahq.com/for-authors

How can we improve computer-brain interfaces for broader and safer use in medicine, research, and daily life?

1)

2)

Dear Master Degree, MPhil, and PhD Research Scholars,

We're excited to invite you to the CIMPA School 2024 on Mathematics for Medicine and Health Sciences at Silpakorn University in Thailand.

The CIMPA School will be held from May 20 to May 31 2024 at our esteemed university campus. This school aims to provide participants with in-depth knowledge and practical skills in the application of mathematics in the fields of medicine and health sciences. The program offers a diverse range of courses and training sessions led by renowned experts in their respective fields.

During the school, you will have the opportunity to attend introductory courses that cover various topics such as pharmacokinetics, disease modeling, big data analysis, and numerical implementation of blood flow. Additionally, advanced courses will delve into specialized areas like big data and machine learning for public health, modeling of waterborne diseases, and coagulation-fragmentation modeling.

The CIMPA School at Silpakorn University will serve as a platform for interdisciplinary exchange, fostering collaborations among participants from different countries and backgrounds. You will not only gain valuable knowledge but also have the chance to network with fellow researchers and professionals, opening doors to future collaborations and opportunities.

We are pleased to inform you that CIMPA is offering financial support for eligible participants. If you require financial assistance, we encourage you to apply for CIMPA financial support through their website: https://www.cimpa.info/en/node/40

To learn more about the CIMPA School at Silpakorn University, please visit our official website: https://sites.google.com/view/cimpa-silpakorn2024/. You will find detailed information regarding the registration procedure, program schedule, and other relevant details.

We believe that your expertise and contributions would greatly enrich the learning experience for all participants. Your presence at the CIMPA School would be highly valued, and we look forward to welcoming you to Silpakorn University.

If you have any questions or require further information, please do not hesitate to reach out to us ( pornsawad_p@su.ac.th or pornsawad_p@silpakorn.edu).

Thank you for your attention, and we hope to see you at the CIMPA School at Silpakorn University.

Best regards,

P. Pornsawad

Coordinators

https://www.igi-global.com/publish/call-for-papers/call-details/7275

Recommended Topics

S-Existence : There is Another Existence of Everything'

This theory could bring revolutionary changes in the field of medicine. Please read and give your feedback. thank you

📢 Call for Papers Announcement: New Asian Journal of Medicine (NAJM) - Volume 2, Issue 1, 2024 📚🔬

🌟 ISSN: 3005-8902

The New Asian Journal of Medicine (NAJM) is excited to invite researchers and clinicians to submit their groundbreaking work for our first issue of 2024. This marks our third serial issue since establishment, and we're proud to continue promoting impactful knowledge in medicine, medical science, and public health. 🌏💉

🎉 2024: A Year of Open Access and No Publication Charges! In our commitment to fostering global research collaborations and ensuring widespread accessibility of vital medical research, NAJM will operate as a fully open-access journal throughout 2024, without any publication charges. 🌐✨

🗓️ Submission Deadline: 15 Mars 2024

📩 For any queries or to submit your work, please reach out to our editorial office at editor@nasianjmed.com. We eagerly await your valuable contributions, which are instrumental in advancing medical knowledge and improving health outcomes worldwide. 💌👩‍🔬

👥 Tag a colleague or a researcher who might be interested! Let's collaborate to advance the frontiers of medical science.